Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 14;19(1):146.
doi: 10.1186/s12891-018-2063-1.

Discontinuation of the PACE Plus trial: problems in patient recruitment in general practice

M Schreijenberg  1 , P A J Luijsterburg  2 , Y D M Van Trier  2 , D Rizopoulos  3 , M A Koopmanschap  4 , L Voogt  5 , C G Maher  6 , B W Koes  2
Affiliations

Discontinuation of the PACE Plus trial: problems in patient recruitment in general practice

M Schreijenberg et al. BMC Musculoskelet Disord. .

Abstract

Background: The PACE Plus trial was a multi-center, double-blinded, superiority randomized controlled trial (RCT) conducted in patients from Dutch general practice to investigate the efficacy of paracetamol and NSAIDs in acute non-specific low back pain (LBP). Because insufficient numbers of patients could be recruited (only four out of the required 800 patients could be recruited over a period of 6 months), the trial was prematurely terminated in February 2017, 6 months after the start of recruitment. This article aims to transparently communicate the discontinuation of PACE Plus and to make recommendations for future studies.

Methods: General Practitioners (GPs) from 36 participating practices received a one-question survey in which they were asked to give the three most important factors that in their opinion contributed to failure of patient recruitment.

Results: GPs of 33 out of 36 (92%) participating practices sent a response. A total of 81 factors were reported. These have been categorized into patient factors (26 out of 81 comments, 32%), GP factors (39 out of 81 comments, 48%) and research factors (16 out of 81 comments, 20%).

Discussion: Patient recruitment in the PACE Plus trial may have failed due to inefficient medication distribution, recruitment of incident rather than prevalent cases, a design that was too complicated, adequate self-management of LBP, patient expectations different from the trial's scope and lack of time of participating GPs. Substantial differences in design may explain why the preceding PACE trial did manage to successfully complete patient recruitment.

Conclusion: Although the PACE Plus trial was terminated as a result of insufficient patient inclusion, the research questions addressed in this trial remain relevant but unanswered. We hope that lessons learned from the discontinuation of PACE Plus and corresponding recommendations may be helpful in the design of upcoming research projects in LBP in general practice.

Trial registration: Dutch Trial Registration NTR6089, registered September 14th 2016.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

The Erasmus MC Medical Research and Ethics Committee has granted approval for the PACE Plus trial (NL54941.078.16). Before enrollment in the PACE Plus trial, written informed consent was collected from participants by a member of the research team.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Schreijenberg M, Luijsterburg PA, Van Trier YD, Rizopoulos D, Koopmanschap MA, Voogt L, Maher CG, Koes BW. Efficacy of paracetamol, diclofenac and advice for acute low back pain in general practice: design of a randomized controlled trial (PACE Plus) BMC Musculoskelet Disord. 2017;18(1):56. doi: 10.1186/s12891-017-1432-5. - DOI - PMC - PubMed
    1. Williams CM, Latimer J, Maher CG, McLachlan AJ, Cooper CW, Hancock MJ, Day RO, McAuley JH, Lin CW. PACE--the first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial. BMC Musculoskelet Disord. 2010;11:169. doi: 10.1186/1471-2474-11-169. - DOI - PMC - PubMed
    1. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, Billot L, Lin CW. PACE--the first placebo controlled trial of paracetamol for acute low back pain: statistical analysis plan. Trials [Electronic Resource] 2013;14:248. - PMC - PubMed
    1. Williams CM, Maher CG, Latimer J, McLachlan AJ, Hancock MJ, Day RO, Lin CW. Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial. Lancet. 2014;384:1586–1596. doi: 10.1016/S0140-6736(14)60805-9. - DOI - PubMed
    1. Thuisarts.nl. [www.thuisarts.nl].

MeSH terms

Substances

Grants and funding

LinkOut - more resources